Christine Hanoun

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Wolfgang Bethge, Peter Martus, Michael Schmitt et al. · Blood · 2022 · 211 citations · Full text

Medicine, Hematology, Oncology +15

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Martin Dreyling, Jeanette K. Doorduijn, Eva Giné et al. · The Lancet · 2024 · 136 citations · Full text

Medicine, Hematology, Oncology +10

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Brian J. Sworder, David M. Kurtz, Stefan Alig et al. · Cancer Cell · 2022 · 133 citations · Full text

Life Sciences, Immunology, Oncology +13

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline¹⁸F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation

Ronald Boellaard, Irène Buvat, Christophe Nioche et al. · Journal of Nuclear Medicine · 2024 · 63 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17